Eat enough iron, but not too much
Patients should not assume BPC-157 or TB-500 are FDA-approved treatments for injury recovery
That's when supplementing Glutathione can make a real difference
Research has found plasma glycine, serine and glutamate concentrations to be consistently altered in metabolic diseases, as are plasma branch chain amino acids (BCAA), isoleucine, leucine, and valine
By eliminating senescent cells, FOXO4-DRI treatment appears to create a more permissive environment for endogenous stem cell activation and tissue renewal, contributing to improvements in organ function and physical capacity
FOXO4-DRI is a D-Retro-Inverso (DRI) isoform peptide a synthetic peptide in which the amino acid sequence of the FOXO4 p53-binding domain has been reversed and all L-amino acids substituted with their D-amino acid counterparts